Log In
BCIQ
Print this Print this
 

Netupitant

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionTachykinin receptor (TACR1; NK1R) antagonist
Molecular Target Tachykinin receptor (TACR1) (NK1R)
Mechanism of ActionTachykinin receptor (TACR1) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationEmesis
Indication DetailsPrevent chemotherapy-induced nausea and vomiting (CINV)
Regulatory Designation
PartnerHelsinn Healthcare S.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today